Matters of legal in nature including licensing, intellectual property, and lawsuits.
Basel, 28 March 2018 Roche announces Japanese court ruled in favour of Chugai in Hemlibra patent litigation Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that a Japanese court (Tokyo District Court) ruled in favour of Chugai Pharmaceutical Co., Ltd, a member of the Roche Group, in the patent litigation case relating to Hemlibra® (emicizumab).... Read more
Basel, 28 March 2018 Roche announces Japanese court ruled in favour of Chugai in Hemlibra patent litigation Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that a Japanese court (Tokyo District Court) ruled in favour of Chugai Pharmaceutical Co., Ltd, a member of the Roche Group, in the patent litigation case relating to Hemlibra® (emicizumab).... Read more
New Salmonella Multiplex PCR Solution for Simultaneous Detection of Three Salmonella Targets in One Rapid Test is Now Certified by AFNOR Real-Time PCR workflow gains NF VALIDATION by AFNOR Certification for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, March 27, 2018 /PRNewswire/ — Laboratories performing tests for poultry producers... Read more
MENLO PARK, Calif., March 22, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware denied a motion to dismiss filed on December 14, 2017 by Oxford Nanopore Technologies, Inc., a wholly-owned... Read more
Toronto, Canada – March 20, 2018 – GE Healthcare is proud to announce SIGNA™ Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in Canada. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design... Read more
HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the use of its market leading bioinformatics solutions for microbiome, metagenomics and other applications. QIAGEN Bioinformatics signed an agreement with genomics big data company CosmosID, Inc. to... Read more
COMPLETES RESTRUCTURING OF CLOSE TO 95% TRANSGENOMIC LIABILITIES NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC, restructuring the final substantial liability of legacy payables inherited as part of the merger with Transgenomic in June 2017. These... Read more
MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,910,956 (the “956 Patent”), entitled “Sequencing using concatemers of copies of sense and antisense strands.” The 956 Patent was... Read more
What is one-piece flow and why it is time to implement this critical “lean” concept? One-piece flow encourages simplified processes, shorter run-times and less waste. A new application note from METTLER TOLEDO describes how implementing this and other lean principles can lower costs and increase quality. Greifensee, 01st February, 2018 – Products and services... Read more
Advanced ICP-MS technology provides new levels of ultralow detection and simplicity in a single high-performance solution ORLANDO, Fla., Feb. 27, 2018 /PRNewswire/ — Pittcon 2018 – Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of trace elements within challenging sample matrices with a new triple quadrupole inductively coupled plasma mass... Read more